SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MEDX ... anybody following?
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
2240 62 0 MEDX
Emcee:  Ed Offstein Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1815Genmab Announces Encouraging Preclinical Data for ofatumumab COPENHAGEN, Denmarnigel bates-9/7/2007
1814Medarex Announces Extension of Broad Antibody Development Relationship with CentIcebrg-9/5/2007
1813A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormoneIcebrg-8/31/2007
1812Genmab reports: genmab.comtom r. phillips-8/21/2007
1811>>CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumotuck-8/20/2007
1810Item 5.02. Departure of Directors or Certain Officers; Election of Directors; ApIcebrg-8/14/2007
1809Roche Files IND for Second Genmab Antibody Friday August 10, 11:56 am ET Summarynigel bates-8/10/2007
1808I think Weber's MDX-010 article is interesting as this is the first time posIcebrg-8/7/2007
1807The current issue of The Oncologist carries two articles on anti-CTLA-4 intervenIcebrg-8/7/2007
1806Study Investigating Vaccine To Treat Brain Tumors Underway [Some more info on tIcebrg-8/4/2007
1805Blockade of IP-10/CXCR3 Promotes Progressive Renal Fibrosis. Nephron Exp NephroIcebrg-8/3/2007
1804Genmab Regains Rights to HuMax-TAC Genmab A/S (OMX (Stockholm: OMX.ST - news) :nigel bates-8/2/2007
1803Erik--I have not communicated with you for a while, so I have some questions forJOEBT1-8/1/2007
1802What a bland statement. <i>"Medarex is full of opportunities, and weIcebrg-7/31/2007
1801Organon And MRC Technology Sign Antibody Development Agreement Article Date: 27 Icebrg-7/28/2007
1800GVAX® Plus Ipilimumab Provides Positive Results in Hormone-Refractory ProstIcebrg-7/28/2007
1799Phase I/II Study of an Anti-CD30 Monoclonal Antibody (MDX-060) in Hodgkin's Icebrg-7/21/2007
1798Medarex Announces Advancement of Antibody Development by Partner Thursday July 1Icebrg-7/19/2007
1797How many $2.7bn pa MABs has MEDX got in the pipeline, anyone ? Message 23710893nigel bates-7/18/2007
1796Probably smart to pursue an obscure indication like this. Amgen hasn't exanigel bates-7/18/2007
1795Muckle-Wells syndrome From Wikipedia, the free encyclopedia Muckle-Wells syndrIcebrg-7/18/2007
1794Medarex Announces Initiation by Licensing Partner of Phase III Clinical Trial fonigel bates-7/18/2007
1793Rising Case Rate and Mortality Documented for C. difficile Colitis URL: medpageIcebrg-7/18/2007
1792The "Naked" Truth About Antibodies For Cancer Therapy Posted on Jul 5tLJM-7/5/2007
1791A phase-I trial of the epidermal growth factor receptor directed bispecific antiIcebrg-7/4/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News